Scleroderma
Vision – To combat scleroderma through a partnership of scientists, clinicians, and consumers
Mission — To fund and facilitate the most promising, highest quality research aimed at understanding mechanisms, improving therapies, and ultimately curing scleroderma for Service Members, Veterans, and the American public
SRP FY20 Stake Holders Meeting Summary
Congressional Appropriations
- $10 million
FY20-21
Funding
Summary
- 21 Awards in FY20-21
- Recent Applications Recommended for Funding
Programmatic
Panels
Peer Review Participants
Last updated Friday, June 13, 2025